内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Bellon Christine. Director active across 1 company, notably Beam Therapeutics Inc.. Aggregated, 20 filings have been logged. Split: 0 buy · 14 sells. Total volume traded: €1.1m. History available since 30 March 2023. The latest transaction was filed on 1 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bellon Christine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
5,956 股@ US$24.5811.2% 占其流量Common StockSEC:0001193125-26-144067:0
20,000 股0Common StockSEC:0001193125-26-140586:0
1,371 股@ US$34.003.3% 占其流量Common StockSEC:0001193125-26-022557:0
2,111 股@ US$33.62196.1% 占其流量Common StockSEC:0001193125-26-016552:0
15,959 股@ US$34.718247.4% 占其流量Common StockSEC:0001193125-26-016552:1
559 股@ US$35.39881.7% 占其流量Common StockSEC:0001193125-26-016552:2
1,254 股@ US$27.102.4% 占其流量Common StockSEC:0001193125-26-002427:0
373 股@ US$24.530.7% 占其流量Common StockSEC:0001193125-25-230148:0
5,674 股@ US$18.35079.6% 占其流量Common StockSEC:0000950170-25-050859:0
20,000 股0Common StockSEC:0000950170-25-049769:0
9,492 股@ US$7.226.5% 占其流量Common StockSEC:0000950170-25-023166:0
1,241 股@ US$24.682.9% 占其流量Common StockSEC:0000950170-25-002358:0
385 股@ US$23.47940.8% 占其流量Common StockSEC:0000950170-24-111739:0
3,401 股@ US$32.1210.1% 占其流量Common StockSEC:0000950170-24-041438:0
27,500 股0Common StockSEC:0000950170-24-040150:0
1,907 股@ US$26.424.6% 占其流量Common StockSEC:0000950170-24-002480:0
4,182 股@ US$7.222.8% 占其流量Common StockSEC:0000950170-23-065868:0
388 股@ US$22.850.8% 占其流量Common StockSEC:0000950170-23-051915:0
931 股@ US$30.312.6% 占其流量Common StockSEC:0000899243-23-010817:0
6,272 股@ US$7.224.1% 占其流量Common StockSEC:0000899243-23-010140:0
About Bellon Christine
Bellon Christine is a declarant linked to Beam Therapeutics Inc. (XNAS), where the listed role is Chief Legal Officer. The record shows 20 filings in total, and across the 20 sampled filings between 2023-03-31 and 2026-04-06, the figures indicate 0 in purchases and 1072953 in sales, with Cession as the dominant transaction nature.